Essa Pharma Inc. (EPIX) NASDAQ

$3.05 0.06 (2.01%)

Market Cap: $134.48M

As of 06/02/23 04:30 PM EDT. Market closed.

(EPIX)

Essa Pharma Inc. (EPIX)
NASDAQ

$3.05
0.06 (2.01%)

Market Cap: $134.48M

As of 06/02/23 04:30 PM EDT. Market closed.

ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate ... read more

ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
50
Address
.
PRICE CHART FOR ESSA PHARMA INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$2.95
Previous Close
$2.99
Days Range
$2.94 - $3.05
52 week range
$1.40 - $5.38
Volume
20,583
Avg. Volume (30 days)
40,696
Market Cap
$134.48M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
44,092,374
Open
$2.95
Previous Close
$2.99
Days Range
$2.94 - $3.05
52 week range
$1.40 - $5.38
Volume
20,583
Avg. Volume (30 days)
40,696
Market Cap
$134.48M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
44,092,374

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ESSA PHARMA INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Parkinson David RossChief Executive OfficerDec 30, 2022 Buy$2.603,0677,97456,542Jan 05, 2023, 06:18 PM
Parkinson David RossChief Executive OfficerDec 22, 2022 Buy$2.3921,36751,06753,475Jan 05, 2023, 06:18 PM
BERGER FRANKLIN MDirectorDec 21, 2022 Sale$2.4172,223174,401718,738Jan 05, 2023, 03:41 PM
BERGER FRANKLIN MDirectorDec 20, 2022 Sale$2.5343,617110,351756,627Jan 05, 2023, 03:41 PM
BERGER FRANKLIN MDirectorDec 16, 2022 Sale$2.6750,000133,500800,244Jan 05, 2023, 03:41 PM
BERGER FRANKLIN MDirectorDec 15, 2022 Sale$2.8882,000235,800900,244Jan 05, 2023, 03:41 PM
BERGER FRANKLIN MDirectorDec 14, 2022 Sale$3.0025,00075,000932,244Jan 05, 2023, 03:41 PM
Wood David S.Chief Financial OfficerDec 30, 2022 Buy$2.608,30221,58533,343Jan 05, 2023, 03:07 PM
BIOTECH GROWTH N V10% OwnerOct 27, 2022 Buy$4.50500,0002,251,1007,879,583Oct 28, 2022, 02:57 PM
BIOTECH GROWTH N V10% OwnerOct 26, 2022 Buy$3.981,500,0005,968,5007,379,583Oct 28, 2022, 02:57 PM
BIOTECH GROWTH N V10% OwnerJul 18, 2022 Buy$3.16300,000946,7405,879,583Jul 20, 2022, 03:21 PM
BIOTECH GROWTH N V10% OwnerJul 15, 2022 Buy$3.13241,665756,7985,579,583Jul 18, 2022, 12:48 PM
BIOTECH GROWTH N V10% OwnerJul 14, 2022 Buy$2.79347,204969,4285,337,918Jul 18, 2022, 12:48 PM
Parkinson David RossChief Executive OfficerJun 30, 2022 Buy$2.964,88714,45632,108Jul 05, 2022, 01:39 PM
BIOTECH GROWTH N V10% OwnerApr 27, 2022 Sale$5.8525,100146,9254,990,714Apr 28, 2022, 12:28 PM
BIOTECH GROWTH N V10% OwnerAug 18, 2021 Buy$8.88250,0002,218,8005,015,814Aug 20, 2021, 12:43 PM
BERGER FRANKLIN MDirectorFeb 22, 2021 Buy$27.0057,0001,539,000957,244Mar 04, 2021, 06:47 PM
BERGER FRANKLIN MDirectorDec 03, 2020 Option Exercise$3.6442,207153,701900,244Jan 11, 2021, 04:42 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Parkinson David RossChief Executive Officer12/30/20227,974
Parkinson David RossChief Executive Officer12/22/202251,067
BERGER FRANKLIN MDirector12/21/2022174,401
BERGER FRANKLIN MDirector12/20/2022110,351
BERGER FRANKLIN MDirector12/16/2022133,500
BERGER FRANKLIN MDirector12/15/2022235,800
BERGER FRANKLIN MDirector12/14/202275,000
Wood David S.Chief Financial Officer12/30/202221,585
BIOTECH GROWTH N V10% Owner10/27/20222,251,100
BIOTECH GROWTH N V10% Owner10/26/20225,968,500
BIOTECH GROWTH N V10% Owner07/18/2022946,740
BIOTECH GROWTH N V10% Owner07/15/2022756,798
BIOTECH GROWTH N V10% Owner07/14/2022969,428
Parkinson David RossChief Executive Officer06/30/202214,456
BIOTECH GROWTH N V10% Owner04/27/2022146,925
BIOTECH GROWTH N V10% Owner08/18/20212,218,800
BERGER FRANKLIN MDirector02/22/20211,539,000
BERGER FRANKLIN MDirector12/03/2020153,701
Load More Insider Transactions
FUNDS WITH A POSITION IN ESSA PHARMA INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
ORBIMED ADVISORS LLC1,198,3370.07%228.04%Other
ADAGE CAPITAL PARTNERS GP, L.L.C.1,042,5310.00694%No changeOther
DRIEHAUS CAPITAL MANAGEMENT LLC264,5710.01%No changeGrowth
D. E. SHAW & CO., INC.172,2210.00055%-31.22%Other
RENAISSANCE TECHNOLOGIES LLC34,6240.00012%ExitedOther
GEODE CAPITAL MANAGEMENT, LLC19,0390.00001%No changeOther
BLACKROCK INC.2,2610%NewOther
CHANGE IN SHARES OUTSTANDING FOR ESSA PHARMA INC
STOCK BUYBACKS FOR ESSA PHARMA INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2023
12/31/2022
0.02%
1Q
03/31/2023
09/30/2022
0.10%
2Q
03/31/2023
06/30/2022
0.13%
3Q
03/31/2023
03/31/2022
0.17%
4Q
03/31/2023
12/31/2021
0.21%
5Q
03/31/2023
09/30/2021
14.56%
6Q
03/31/2023
06/30/2021
19.35%
7Q
03/31/2023
03/31/2021
26.32%
8Q
03/31/2023
12/31/2020
32.21%
9Q
Load More

Period of Report: 03/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2022
0.02%
1Q
09/30/2022
0.10%
2Q
06/30/2022
0.13%
3Q
03/31/2022
0.17%
4Q
12/31/2021
0.21%
5Q
09/30/2021
14.56%
6Q
06/30/2021
19.35%
7Q
03/31/2021
26.32%
8Q
12/31/2020
32.21%
9Q
Load More